Craving - A concise concept?;CRAVING - EINE AUSREICHEND FUNDIERTES KONZEPT?

Fortschritte der Neurologie Psychiatrie

Volumn 64, Issue 4, 1996, Pages 142-152

  Wetterling, T ^a   Veltrup, C ^a   Junghanns, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; ACAMPROSATE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMANTADINE; ANTIDEPRESSANT AGENT; ATENOLOL; BROMOCRIPTINE; CALCIUM ANTAGONIST; CITALOPRAM; CLONIDINE; DESIPRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DOXEPIN; ENALAPRIL; FLUPENTIXOL; GLUTAMATE RECEPTOR ANTAGONIST; HALOPERIDOL; LEVODOPA; LISURIDE; LOFEXIDINE; NALOXONE; NALTREXONE; OPIATE ANTAGONIST; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; TIAPRIDE;

BIOCHEMISTRY; DRUG DEPENDENCE; DRUG THERAPY; DRUG WITHDRAWAL; ETIOLOGY; HUMAN; REVIEW; ADDICTION; ALCOHOLISM; MOTIVATION; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; SOCIAL ENVIRONMENT; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

ALCOHOLISM; HUMANS; MOTIVATION; PATIENT COMPLIANCE; SOCIAL ENVIRONMENT; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 0029665251     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996380     Document Type: Review

References (136)

1. Adinoff, B., P. R. Martin, G. H. Bone, M. J. Eckardt, L. Roehrich, D. T. George, H. B. Moss, R. Eskay, M. Linnoila, P. W. Gold: Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence. Arch. Gen. Psychiatry 47 (1990) 325-330
2. American Psychiatric Association: Diagnostic and statistic manual of mental disorders. 4th edition. DSM-IV. American Psychiatric Press, Washington DC 1994
3. Ballenger, J. C., R. M. Post: Kindling as a model for alcohol withdrawal syndromes. Br. J. Psychiatry 133 (1978) 1-14
4. Bancroft, J., A. Cook, L. Williamson: Food craving, mood and the menstrual cycle. Psychol. Med. 18 (1988) 855-860
5. Banger, M., K. Mann, C. Hiemke: Alcoholcraving, globale Selbsteinschätzung und endokrine Alterationen im akuten Alkoholentzug. Sucht, Sonderband (1995) 47-50
6. Beck, O., S. Borg, S. Holmstedt, H. Kvande, R. Skröder: Concentration of serotonin metabolites in the cerebrospinal fluid from alcoholics before and during disulfiram therapy. Acta pharmacol. et toxicol. 47 (1980) 305-307
7. Björkqvist, S.-E., M. Isohanni, R. Mäkelä, L Malinen: Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre double-blind comparison with placebo. Acta Psychiat. Scand. 53 (1976) 333-342
8. Blum, K.: Das somatopsychische Syndrom: Ein Modell zur Bedeutung neurogenetischer Faktoren in der Genese von Suchter-krankungen. In: Heide, M., T. Klein, H. Lieb (Hrsg.): Abhängigkeit zwischen biochemischem Programm und steuerbarem Verhalten. H. N. Druck + Verlag, Bonn (1991) 65-95
9. Bohn, M. J., D. Hersh: Drugs for the treatment of psychiatric comorbidity in alcoholics: recent developments. In: Kranzler, H. R. (Hrsg.): The pharmacology of alcohol abuse. Springer, Berlin (1995) 415-441
10. Bokström, K., J. Balldin: A rating scale for assessment of alcohol withdrawal psychopathology (AWIP). Alcohol. Clin. Exp. Res. 16 (1992) 241-249
11. Borg, S., H. Kvande, G. Sedvall: Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Science 213 (1981) 1135-1137
12. Borg, S., H. Kvande, U. Rydberg, L Terenius, A. Wahlström: Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal. Psychopharmacol. 78 (1982) 101-103
13. Borg, S., A. Czarnecka, H. Kvande, D. Mossberg, G. Sedvall: Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Alcohol. Clin. Exp. Res. 7 (1983) 411-415
14. Borg, S., H. Kvande, P. Liljeberg, D. Mossberg, P. Valverius: 5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions. Alcohol 2 (1985) 415-418
15. Borg, V.: Bromocriptine in the prevention of alcohol abuse. Acta Psychiatr. Scand. 68 (1983) 100-110
16. Bruno, F.: Buspirone in the treatment of alcoholic patients. Psychopathology 22, Suppl. 1 (1989) 49-59
17. 2-adrenergic agonist treatment. Alcohol. Clin. Exp. Res. 13 (1989) 361-364
18. Dilling, H., W. Mombour, M. H. Schmidt: Internationale Klassifikation psychischer Störungen. ICD-10. 2. Aufl., Huber, 1993
19. Dongier, M., L. Vachon, G. Schwanz: Bromocriptine in the treatment of alcohol dependence. Alcohol. Clin. Exp. Res. 15 (1991) 970-977
20. Drummond, D. C., T. Cooper, S. P. Glautier: Conditioned learning in alcohol dependence: implications for cue exposure treatment. Br. J. Addiction 85 (1990) 725-743
21. Ehrman, R. N., S. J. Robbins, A. R. Childress, C P. O'Brien: Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology 107 (1992) 523-529
22. Engel, R. R., C. Schöchlin: Therapeutische Strategien zur Überwindung der Alkoholsucht: Metaanalyse klinischer Prüfungen. Sucht (Sonderband) (1995) 102-105
23. Facchinetti, F., F. Petraglia, G. Nappi, E. Martignoni, E. Sinforiani, E. Bono, A. R. Genazzani: Functional opoid activity variates according to different fashion of alcohol abuse. Subst. Alc. Actions/ Misuse 5 (1985) 281-291
24. Falkai, B. A., V. M. Camp, D. C. Davis, J. D. Lenton, M. Kutner: Elevation of plasma salsolinol sulfate in chronic alcoholics as compared to nonalcoholics. Alcohol. Clin. Exp. Res. 13 (1989) 155-163
25. Flowers, Q., I. R. Elder, J. Voris, P. S. Sebastian, O. Blevins, J. Dubois: Daily cocaine craving in a 3-week inpatient treatment program. J. Clin. Psychol. 49 (1993) 292-297
26. Gallimberti, L., M. Ferri, S. D. Ferrara, F. Fadda, G. L. Cessa: Gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol. Clin. Exp. Res. 16 (1992) 673 -676
27. Gawin, F. H., D. Allen, B. Humblestone: Outpatient treatment of "crack" cocaine smoking with flupenthixol decanoate. A preliminary report. Arch. Gen. Psychiatry 46 (1989) 322-325
28. Gawin, F. H., H. D. Klebe, R. Byck, B. J. Rounsaville, T. R. Kosten, P. I. Jatlow, C. Morgan: Desipramine facilitation of initial cocaine abstinence. Arch. Gen. Psychiatry 46 (1989) 117-121
29. Gawin, F. H., C. Morgan, T. R. Kosten, H. D. Kleber: Double-blind evaluation of the effect of acute amantadine on cocaine craving. Psychopharmacology 97 (1989) 402-403
30. Genazzani, A. R., G. Nappi, F. Facchinetti, G. L. Mazzella, F. Parrani, E. Sinforiani, F. Petraglia, F. Savoldi: Central deficiency of β-endorphin in alcohol addicts. Clin. Endocrin. Metab. 55 (1982) 583-586
31. George, D. T., T. Lindquist, R. R. Rawlings, M. J. Eckardt, H. Moss, C. Mathis, P. R. Martin, M. Linnoila: Pharmacologic maintenance of abstinence in patients with alcoholism: no efficacy of 5-hydroxytryptophan or levodopa. Clin. Pharmacol. Ther. 52 (1992) 553-560
32. Gianoulakis, C., P. Angelgianni, M. Meany, J. Thavundayil, V. Tawar: Endorphins in individuals with high and low risk for development of alcoholism. In: Reid, L. D. (Hrsg.): Opioids, bulimia, and alcohol abuse and alcoholism. Springer, Berlin (1990) 229-246
33. Gillin, J. C., L. Pulvirenti, N. Withers, S. Golshan, G. Koob: The effects of Iisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report. Biol. Psychiatry 35 (1994) 843-849
34. Glassmann, A. H., W. K. Jackson, B. T. Walsh, S. P. Roose, B. Rosenfeld: Cigarette, Craving, smoking withdrawal, and clonidine. Science 226 (1984) 864-866
35. Gotwyn, D. H.: Cocaine abuse treated with phenelzine. Int. J. Addict. 23 (1988) 897-905
36. Gorelick, D. A., A. Paredes: Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol. Clin. Exp. Res. 16 (1992) 261-265
37. Gossop, M., J. Powell, S. Grey, P. Hajek: What do opiate addicts and cigarette smokers mean by "craving"? A pilot study. Drug Alcohol Depend. 26 (1990) 85-87
38. Grant, K. A., P. L Huffman, B. Tabakoff: Neurobiological and behavioral approaches to tolerance and dependence. In: Edwards, C., M. Lader (Hrsg.): The nature of dependence. Oxford University Press, Oxford (1990) 135-162
39. Halikas, J. A., K. L. Kuhn, R. Crosby, G. Carlson, F. Crea: The measurement of craving in cocaine patients using the Minnesota Cocaine Craving Scale. Compr. Psychiatry 32 (1991) 22-27
40. Hawley, R. J., L. F. Major, E. Schulman, P. J. Trocha, J. K. Takenaga, G. N. Catravas: Cerebrospinal fluid cyclic nucleotides and GABA do not change in alcohol withdrawal. Life Sci. 28 (1981) 295-299
41. Hawley, R. J., L. F. Major, E. Schulman, R. Lake: CSF levels of norepinephrine during alcohol withdrawal. Arch. Neurol. 38 (1981) 289-292
42. Herz, A.: Neurobiologische Grundlagen des Suchtgeschehens. Nervenarzt 66 (1995) 3-14
43. Hollander, E., E. Nunes, C. M. de Caria, F. M. Quitkin, T. Cooper, S. Wagner, D. F. Klein: Dopaminergic sensitivity and cocaine abusus: response to apomorphine. Psychiat. Res. 33 (1990) 161-169
44. Horwitz, R. I., L. D. Gottlieb, M. L Kraus: The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. Arch. Intern. Med. 149 (1989) 1089-1093
45. Hüllinghorst, R.: Zur Versorgung Suchtkranker in Deutschland. DHS-Jahrbuch Sucht '94. Neuland, Geesthacht (1993) 23-37
46. Hurd, Y. L., M. Herkenham: Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13 (1993) 357-369
47. Karras, A., J. M. Kane: Naloxone reduces cigarette smoking. Life Sci. 27 (1980) 1541-1545
48. Kemper, A., U. Feest, B. Nickel: Woraus resultiert die erhöhte Salsolinol-Ausscheidung nach längerem Alkoholentzug? In: Gaebel, W., G. Laux (Hrsg.): Biologische Psychiatrie-Synopsis 1990/ 91. Springer, Berlin (1992) 474-476
49. Knoblich, G., D. Curtis, W. O. Faustman, V. Zarcone, S. Stewart, I. Mefford, R. King: Increased CSF HVA with craving in long-term abstinent cocaine abusers. Biol. Psychiatry 32 (1992) 96-100
50. Kozlowski, L. T., D. A. Wilkinson: Use and misuse of the concept of craving by alcohol, tobacco, and drug researchers. Br. J. Addiction 82 (1987) 31-36
51. Kranzler, H. R., L. O. Bauer: Bromocriptine and cocaine cue reactivity in cocaine-dependent patients. Br. J. Addiction 87 (1992) 1537-1548
52. Kranzler, H. R., D. J. Wallington: Serum prolactin level, craving, and early discharge from treatment in cocaine-dependent patients. Am. J. Drug Alcohol Abuse 18 (1992) 187-195
53. Kranzler, H. R., J. A. Burleson, F. K. Del Boca, T. F. Babor, P. Korner, J. Brown, M. J. Bohn: Buspirone treatment of anxious alcoholics. Arch. Gen. Psychiatry 51 (1994) 720-731
54. Ladewig, D.: Dependence liability of the benzodiazepines. Drug Alcohol Depend. 13 (1984) 139-149
55. Ladewig, D., T. Knecht, P. Leher, A. Fendl: Acamprosat - ein Stabilisierungsfaktor in der Langzeitentwöhnung von Alkoholabhängigen. Ther. Rundschau 50 (1993) 182-188
56. Lee, M. A., M. M. Brown, J. F. Nash, H. Y. Meltzer: Neuroendocrine measures of dopaminergic function in chronic cocaine users. Psychiat. Res. 33 (1990) 151-159
57. Lejoyeux. M., J. Ades: Evaluation of lithium treatment in alcoholism. Alcohol Alcoholism 28 (1993) 273-279
58. Lesch, O. M., M. Musalek, A. Nimmerichter, H. Walter: Chronischer Alkoholismus: Gibt es ein biologisch bedingtes Alkohol-verlangen? Sucht 38 (1992) 85-88
59. Lhuintre, J. P., M. Daoust, N. D. Moore, P. Chretien, C. Saligaut, G. Tran, F. Bosimare, B. Hillemand: Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet 1 (1985) 1014-1016
60. Lhuintre, J. P., N. D. Moore, G. Tran, L Stern, S. Lanrenon, M. Daousi, P. Parot, P. Ladure, C. Libert, F. Boismare, B. Hillemand: Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcoholism 25 (1991) 613-622
61. Liljeberg, P., D. Mossberg, S. Borg: Clinical conditions and central noradrenergic activity in long term abstinent alcoholic patients. Alcohol Alcoholism, Suppl. 1 (1987) 615-618
62. Lindenmeyer, J., H. Bents, W. Fiegenbaum, W. Ströhm: In der Realität ist alles anders. Exposition in-vivo bei der Rückfallbe-handlung von Alkohol- und Medikamentenabhängigen. Vortrag auf dem 10. Kongreß für Klinische Psychologie und Psychotherapie vom 20.-25.2. 1994, Berlin
63. Linnoila, M., I. Mefford, D. Nutt, B. Adinoff: Alcohol withdrawal and noradrenergic function. Ann. Int. Med. 107 (1987) 875-889
64. Lucki, I., J. R. Volpicelli, E. Schweizer: Differential craving between recovering abstinent alcoholic-dependent subjects and therapeutic users of benzodiazepines. NIDA Res. Monogr. 105 (1991) 322-323
65. Ludwig, A. M., L. H. Stark: Alcohol craving: subjective and situational aspects. Quart. J. Stud. Alcohol 35 (1974) 899-905
66. Ludwig, A. M., A. Wikler, L. H. Stark: The first drink. Psychobiological aspects of craving. Arch. Gen. Psychiatry 30 (1974) 539-547
67. Ludwig, A. M.; Pavlov's "bells" and alcohol craving. Addict. Behav. 11 (1986) 87-91
68. Malcolm, R., R. F. Anton, C. L. Randall, A. Johnston, K. Brady, A. Thevros: A placebo controlled trial of buspirone in anxious inpatient alcoholics. Alcohol. Clin. Exp. Res. 16 (1992) 1007-1013
69. Marlatt, G. A.: Relapse prevention. Theoretical rationale and overview of the model. In: Marlatt, G. A., J. R. Gordon (Hrsg.): Relapse prevention. Guilford, New York (1985) 3-70
70. Martin, S. D., V. K. Yeragani, R. Lodhi, M. P. Galloway: Clinical ratings and plasma HVA during cocaine abstinence. Biol. Psychiatry 26 (1989) 356-362
71. McCusker, C. G., K. Brown: The cue-responsivity phenomenon in dependent drinkers: "personality" vulnerability and anxiety as intervening variables. Br. J. Addiction 86 (1991) 905-912
72. Mendelson, J. H., S. K. Teoh, U. Lange, N. K. Mello, R. Weiss, A. Skupny, J. T. I. Ellingboe: Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am. J. Psychiatry 145 (1988) 1094-1098
73. Merkangas, K. R.: The genetic epidemiology of alcoholism. Psychol. Med. 20 (1990) 11-22
74. Miller, N. S., M. S. Gold: The diagnosis of marijuana (cannabis) dependence. J. Subst. Abuse Treat. 6 (1989) 183-192
75. Modell, J. G., F. B. Glaser, L. Cyr, J. M. Mountz: Obsessive and compulsive characteristics of craving for alcohol in alcohol abuse and dependence. Alcohol. Clin. Exp. Res. 16 (1992) 272-274
76. Modell, J. G., J. M. Mountz, F. B. Glaser, J. Y. Lee: Effect of haloperidol on measures of craving and impaired control in alcoholic subjects. Alcohol. Clin. Exp. Res. 17 (1993) 234-240
77. Murayama, M., S. Higuchi, M. Hayashida: A study on preventive measures for redrinking in alcoholics. Arukoru Kenkyuto Yakubutsu Ison 29 (1994) 139-146
78. Nalpas, B., H. Dabadie, P. Parot, J. Paccalin: L'acamprosate. De la pharmacologie a la clinique. Encephale 16 (1990) 175-179
79. Naranjo, C. A., K. E. Kadlec, P. Sanhueza, D. Woodley-Remus, E. M. Sellers: Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics. Clin. Pharmacol. Ther. 50 (1991) 96-106
80. Naranjo, C. A., C. X. Poulos, K. E. Bremner, K. L. Lanctot: Citalopram decreases desirability, linking, and consumption of alcohol in alcohol-dependent drinkers. Clin. Pharmacol. Ther. 51 (1992) 729-739
81. Naranjo, C. A., K. E. Bremner, K. L. Lanctot: Effects of citalopram and a brief psychosocial intervention on alcohol intake, dependence and problems. Addiction 90 (1995) 87-99
82. Negrete, J. C., S. Emil: Cue-evoked arousal in cocaine users: a study of variance and predictive value. Drug Alcohol Depend. 30 (1992) 187-192
83. Newlin, D. B., B. Hotchkiss, W. M. Cox, F. Rauscher, T. K. Li: Autonomic and subjective responses to alcohol stimuli with appropriate control stimuli. Addict. Behav. 14 (1989) 625-630
84. Newlin, D. B.: A comparison of drug conditioning and craving for alcohol and cocaine. In: Galanter, M. (Hrsg.): Recent developments in alcoholism. Vol. 10. Alcohol and cocaine, similarities and differences. Plenum Press, New York (1992) 147-164
85. Nunn-Thompson, C. L., P. A. Simon: Pharmacotherapy for smoking cessation. Clin. Pharm. 8 (1989) 710-720
86. O'Connor, P. G., L. D. Gottlieb, M. L Kraus, S. R. Segal, R. I. Horwitz: Social and clinical features as predictors of outcome in outpatient alcohol withdrawal. J. Gen. Intern. Med. 6 (1991) 312-316
87. O'Malley, S. S., A. J. Jaffe, G. Chang, R. S. Schottenfeld, R. E. Meyer, B. Roundsaville: Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 881-887
88. Peters, D. H., D. Faulds: Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs 47 (1994) 1010-1032
89. Pickens, R. W., C. E. Johanson: Craving: consensus of status and agenda for future research. Drug Alcohol Depend. 30 (1992) 127 -131
90. Podschus, J., S. Kuhn, K. J. Gräf, H. Rommelspacher, L G. Schmidt: Alkoholverlangen und dopaminerge Sensitivität: Untersuchungen mit Apomorphin. Sucht 38 (1992) 97-99
91. Podschus, J., F. Krüger, P. Neumann, H. Rommelspacher, L. Schmidt: Erfassung von "Craving" im Verlauf einer ambulanten Entwöhnungsbehartdlung von Alkoholabhängigen. Sucht, Sonderheft (1995) 163-165
92. Ranking, H., R. Hodgson, T. Stockwell: The concept of craving and its measurement. Behavor Res. Ther. 17 (1979) 389-396
93. Regier, D. A., M. E. Farmer, D. S. Rae, B. Z. Locke, S. J. Keith, L. L. Judd, F. K. Goodwin: Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 264
94. Richter, G., N. N. Ivanec, G. V. Morozov: Einteilung des Alkoholismus. In: Nickel, B., G. V. Morozov (Hrsg.): Alkoholbedingte Krankheiten. Grundlagen und Klinik. Verlag Volk und Gesundheit (1989) 36-50
95. Robbins, S. J., R. N. Ehrman, A. R. Childress, C. P. O'Brien: Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride. Addict. Behav. 17 (1992) 491-499
96. Rommelspacher, H., L. G. Schmidt, T. May: Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics. Alcohol. Clin. Exp. Res. 15 (1991) 553-559
97. Rommelspacher, H., L. G. Schmidt: Pathobiochemische und pharmakologische Aspekte der Abhängigkeit. In: Tretter, F., S. Bussello-Spieth, W. Bender (Hrsg.): Therapie von Entzugssyndromen. Springer, Berlin (1994) 28-46
98. 98 Roy, A., M. Linnoila: CSF studies on alcoholism and related behaviours. Prog. Neuropsychopharmacol. Biol. Psychiatry 13 (1989) 505-511
99. Rozin, P., C. Stoess: Is there a general tendency to become addicted? Addict. Behav. 18 (1993) 81-87
100. Savoldi, F., G. L. Mazzella, F. Facchinetti, G. Nappi, F. Petraglia, E. Sinforiani, D. Parrini, A. R. Genazzani: Beta-endorphin, beta-lipotropin and adrenocorticotrophic hormone levels in cerebrospinal fluid, and brain damage in chronic alcoholics. Eur. Neurol. 22 (1983) 265-271
101. Schafer, J., S. A. Brown: Marijuana and cocaine effect expectancies and drug use patterns. J. Consult. Clin. Psychol. 59 (1991) 558-565
102. Schmidt, L. G., H. Rommelspacher: Biologische Marker bei Abhängigkeitserkrankungen. In: Gaebel, W., G. Laux (Hrsg.): Biologische Psychiatrie-Synopsis 1990/91, Springer, Berlin (1992) 3-13
103. Schmidt, L G., P. Dufeu, S. Kuhn, H. Rommelspacher: Perspektiven einer Pharmakotherapie der Alkoholabhängigkeit. Nervenarzt 66 (1995) 323-330
104. Schumann, J., L. Kraus: Befragungen zum Konsum von Alkohol, Tabak, Medikamenten und illegalen Drogen - Eine Pilotstudie. Sucht (Sonderband) (1995) 9-12
105. Shaw, G. K., S. K. Majumdar, S. Waller, J. MacGarvie, G. Dunn: Tiapride in the long-term management of alcoholics of anxious or depressive temperament. Br. J. Psychiatry 150 (1987) 164-168
106. Sherman, J. E., M. C. Zinser, S. I. Sideroff, T. B. Baker: Subjective dimensions of heroin urges: influence of heroin-related and affectively negative stimuli. Addict. Behav. 14 (1989) 611-623
107. Shiffman, S. M., M. E. Jarvik: Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 50 (1976) 35-39
108. Sitharthan, T., D. Mcgrath, G. Sitharthan, J. B. Saunders: Meaning of craving in research on addiction. Psychol. Rep. 71 (1992) 823 -826
109. Sjöquist, B., S. Borg, H. Kvande: Catecholamine derived compounds in urine and cerebrospinal fluid from alcoholics during and after long-standing intoxication. Substance and alcohol actions/misuse 2 (1981) 63-73
110. Solomon, R.: The opponent process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am. Psychologist 35 (1980) 691-712
111. Stockwell, T.: Is there a better word than "craving"? Br. J. Addiction 82 (1987) 44-45
112. Swift, R. M., R. L. Stout: The relationship between craving, anxiety, and other symptoms in opioid withdrawal. J. Subst. Abuse 4 (1992) 19-26
113. Tabakoff, B.: One man's craving is another man's dependence. Br. J. Addiction 85 (1990) 1253-1254
114. Täschner, K. L.: A controlled comparison of clonidine and doxepin in the treatment of the opiate withdrawal syndrome. Pharmacopsychiatry 19 (1986) 91-95
115. Teller, D. W., P. Devenyi: Bromocriptine in cocaine withdrawal-does it work? Int. J. Addict. 23 (1988) 1197-1205
116. Tiffany, S. T., E. Singleton, C. A. Haertzen, J. E. Henningfield: The development of a cocaine craving questionnaire. Drug Alcohol Depend. 34 (1993) 19-28
117. Tollefson, G. D., J. Montague-Clouse, S. L. Tollefson: Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with selective serotonergic drug (buspirone). J. Clin. Psychopharmacol. 12 (1992) 19-26
118. Tyrer, P., S. Murphy, P. Riley: The benzodiazepine withdrawal symptoms questionnaire. J. Affect. Dis. 19 (1990) 53-61
119. 2 receptor genes. TINS 16 (1993) 83-88
120. Velleman, R.: Counselling for Alcohol Problems. Sage Publications, London 1994
121. Veltrup, C.: Eine empirische Analyse des Rückfallgeschehens bei entzugsbehandelten Alkoholabhängigen. In: Körkel, J., G. Lauer, R. Scheller (Hrsg.): Brennpunkte der Rückfallforschung. Springer, Berlin 1993
122. Veltrup, C.: Erfassung des "Craving" bei Alkoholabhängigen mit Hilfe eines neuen Fragebogens (Lübecker Craving-Risiko-Rück-fall-Fragebogen). Wiener klin. Wschr. 106 (1994) 75-79
123. Veltrup, C., T. Wetterung: Die psychometrische Erfassung des Craving bei entzugsbehandelten Alkoholabhängigen. In: Buchkremer, H., K. Mann (Hrsg.): Suchterkrankungen, Springer (in Druck)
124. Volpicelli, J. R., A. I. Alterman, M. Hayashida, C. P. O'Brian: Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 49 (1992) 876-880
125. von Bardeleben, U., I. Heuser, F. Holsboer: Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoneuroendocrinology 14 (1989) 441-449
126. Voris, J., I. Elder, P. Sebastian: A simple test of cocaine craving and related responses. J. Clin. Psychol. 47 (1991) 320-323
127. Wallace, B. C.: Psychological and environmental determinants of relapse in crack cocaine smokers. J. Subst. Abuse Treat. 6 (1989) 95-106
128. Weddington, W. W., B. S. Brown, C. A. Haertzen, E. J. Cone, E. M. Dax, R. I. Herning, B. S. Michaelson: Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch. Gen. Psychiatry 47 (1990) 861-868
129. Weddington, W. W., B. S. Brown, C. A. Haertzen, J. M. Hess, J. R. Mahaffey, A. F. Kolar, J. H. Jaffe: Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am. J. Drug Alcohol Abuse 17 (1991) 137-152
130. Weiss, R. D., S. M. Mirin, R. L. Bartel: Cocaine. 2nd. edition, American Psychiatric Press (1994) 51-70
131. West, R.: Use and misuse of craving. Br. J. Addiction 82 (1987) 39-41
132. West, R., P. Hajek, M. Belcher: Time course of cigarette withdrawal symptoms while using nicotine gum. Psychopharmacology 99 (1989) 143-145
133. Wetterung, T.: Delir-Stand der Forschung. Fortschr. Neurol. Psychiat. 62 (1994) 380-389
134. wise, R. A.: Action of drugs of abuse on the brain reward systems. Pharmacol. Biochem. Behav. 13 (1980) 213-223
135. Wolfsohn, R., M. Sanfilipo, B. Angrist: A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinence. Neuropsychopharmacology 9 (1993) 49-53
136. Wurtman, J. J.: Carbohydrate craving, mood changes, and obesity. J. Clin. Psychiatry 49, Suppl. (1988) 37-39